ArticleJournal of translational medicine2022

SPTBN1 abrogates renal clear cell carcinoma progression via glycolysis reprogramming in a GPT2-dependent manner.

Jiajin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.